<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Neurol</journal-id>
      <journal-title>BMC Neurology</journal-title>
      <issn pub-type="epub">1471-2377</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">15579201</article-id>
      <article-id pub-id-type="pmc">539263</article-id>
      <article-id pub-id-type="publisher-id">1471-2377-4-22</article-id>
      <article-id pub-id-type="doi">10.1186/1471-2377-4-22</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Androgen-induced cerebral venous sinus thrombosis in a young body builder: case report</article-title>
      </title-group>
      <contrib-group>
        <contrib id="A1" corresp="yes" contrib-type="author">
          <name>
            <surname>Sahraian</surname>
            <given-names>Mohammad Ali</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>msahrai@sina.tums.ac.ir</email>
        </contrib>
        <contrib id="A2" contrib-type="author">
          <name>
            <surname>Mottamedi</surname>
            <given-names>Mahmood</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>motamedi@sina.tums.ac.ir</email>
        </contrib>
        <contrib id="A3" contrib-type="author">
          <name>
            <surname>Azimi</surname>
            <given-names>Amir Reza</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>amirreza_azimi@yahoo.com</email>
        </contrib>
        <contrib id="A4" contrib-type="author">
          <name>
            <surname>Moghimi</surname>
            <given-names>Babak</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>moghimi@ams.ac.ir</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Department of Neurology, Sina Hospital, Tehran University of Medical Sciences, Hassan Abad Square, Imam Khomini Street, Tehran, Iran</aff>
      <pub-date pub-type="collection">
        <year>2004</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>3</day>
        <month>12</month>
        <year>2004</year>
      </pub-date>
      <volume>4</volume>
      <fpage>22</fpage>
      <lpage>22</lpage>
      <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2377/4/22"/>
      <history>
        <date date-type="received">
          <day>21</day>
          <month>9</month>
          <year>2004</year>
        </date>
        <date date-type="accepted">
          <day>3</day>
          <month>12</month>
          <year>2004</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2004 Sahraian et al; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2004</copyright-year>
        <copyright-holder>Sahraian et al; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p>
          <!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author>
               Sahraian
               Ali
               Mohammad
               
               msahrai@sina.tums.ac.ir
            </dc:author><dc:title>
            Androgen-induced cerebral venous sinus thrombosis in a young body builder: case report
         </dc:title><dc:date>2004</dc:date><dcterms:bibliographicCitation>BMC Neurology 4(1): 22-. (2004)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-2377(2004)4:1&#x0003c;22&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-2377</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>-->
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>Background</title>
          <p>Cerebral venous sinus thrombosis is an infrequent disease with a variety of causes. Pregnancy, puerperium, contraceptive pills and intracranial infections are the most common causes. The patient may present with headache, focal neurological deficits and seizures.</p>
          <p>The clinical outcome is highly variable and treatment with heparin is advised.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>The patient is a 22 year old male who presented with headache, repeated vomiting and papilledema.</p>
          <p>He was a bodybuilder doing exercise since 5 years ago, who had used nandrolone decaonoate 25 milligrams intramuscularly during the previous 5 months. Brain MRI and MRV showed superior sagital and transverse sinus thrombosis and extensive investigations did not reveal any known cause.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>We suggested that androgen was the predisposing factor in our patient. Androgens may increase coagulation factors or platelet activity and cause arterial or venous thrombosis.</p>
          <p>As athletes may hide using androgens it should be considered as a predisposing factor for thrombotic events in such patients.</p>
        </sec>
      </abstract>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Cerebral venous sinus thrombosis (CVST) is a disease with a wide spectrum of non specific clinical signs and symptoms, including headache, focal neurological deficits, seizures and coma.</p>
      <p>The clinical outcome is highly variable; patients may recover completely or may develop severe and lasting neurological deficits [<xref ref-type="bibr" rid="B1">1</xref>].</p>
      <p>There are many causes for this disease but the most common predisposing factors are pregnancy, puerperium, contraceptive pills, coagulopathies and intracranial infections [<xref ref-type="bibr" rid="B2">2</xref>].</p>
      <p>There are few reports of patients with CVST after androgen therapy. We present a young bodybuilder man who developed CVST with abusing androgens for increasing muscle mass.</p>
    </sec>
    <sec>
      <title>Case presentation</title>
      <p>In May 2004 a 22 year old male was admitted to our department with chief complaints of headache and vomiting.</p>
      <p>The patient was well till 10 days prior to admission that developed progressive, intense bitemporal headache exacerbated with bending.</p>
      <p>The patient also had history of malaise, nausea and several episodes of vomiting from 3 days before admission. The only objective finding on physical examination was bilateral papilledema. The patient was a body builder doing exercise from 5 years ago who had used nandrolone decaonoate 25 mg once or twice a week during the last 5 months. He had injected 20 ampoules in this period.</p>
      <p>Brain computed tomography without contrast was done for the patient which showed cord sign, emergency MR imaging including T1 &#x2013; T2, weighted and MRV showed prominent superior sagital and transverse sinus thrombosis. The C.S.F opening pressure was 480 mm/H2o without any other abnormality. Heparin 80 IU/kg started as loading dose then continued 1000 IU/ hr for 10 days. On the 5<sup>th </sup>day of treatment headache resolved and warfarin added to heparin.</p>
      <p>Laboratory tests including antithrombin III activity, protein C, S factor V leiden, Plasma hemocystein and anticardiolipin were all within normal limits.</p>
      <p>The patient was discharged in a good condition and was maintained on 6 months warfarin protcol.</p>
    </sec>
    <sec>
      <title>Discussion</title>
      <p>There are few reports of CVST following androgen therapy [<xref ref-type="bibr" rid="B3">3</xref>], but there is just one reported case of CVST in androgen using young body builder [<xref ref-type="bibr" rid="B4">4</xref>]. The anabolic activity of testosterone and its derivatives is primarily manifested in its myotrophic actions which result in greater muscle mass and strength.</p>
      <p>This has led to widespread use of androgenic anabolic steroids by athletes at all levels. Nandrolone decaonoate is a synthetic anabolic steroid. In focus on homeostasis system the most important factors under testosterone regulation are fibrinogen, Plasminogen activator inhibitor-1 (PAI &#x2013; 1) and platelet aggregability.</p>
      <p>The current data indicate that testosterone lowers fibrinogen and PAI &#x2013; 1, however these anticoagulatory and profibrinolytic may be opposed by proaggregatory effects on platelets because high dosages of androgens were found to decrease cycloxygenase activity and thereby increase platelet functions [<xref ref-type="bibr" rid="B5">5</xref>].</p>
      <p>Proaggregatory effect of testosterone and other synthetic androgens become more reliable theory for CVST, according to recent publication [<xref ref-type="bibr" rid="B6">6</xref>].</p>
    </sec>
    <sec>
      <title>Conclusions</title>
      <p>This case report presents a patient with CVST following exogenous androgen usage with a mechanism which is not completely understood, but it may be related to platelet activation or an increase in coagulation factors. As androgen use may be frequent and hidden in athletes, it may be an underestimated cause of cerebral venous thrombosis in young adults and careful history should be taken in these groups of patients.</p>
    </sec>
    <sec>
      <title>Lists of abbreviations</title>
      <p>CVST: cerebral venous sinus thrombosis</p>
      <p>PAI-1: Plasminogen activator inhibitor-1</p>
      <p>MRI: magnetic resonance imaging</p>
      <p>MRV: magnetic resonance venography</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The author(s) declare that they have no competing interests.</p>
    </sec>
    <sec>
      <title>Authors' contributions</title>
      <p>M.A.S: Admitting and treating the case, preparing the article.</p>
      <p>M.M : Revising the article.</p>
      <p>A.R.A : searching previous articles, preparing case presentation part.</p>
      <p>B.M : searching previous articles, preparing background.</p>
      <fig position="float" id="F1">
        <label>Figure 1</label>
        <caption>
          <p>T1 weighted horizontal nonGd Images show transverse sinus thrombosis.</p>
        </caption>
        <graphic xlink:href="1471-2377-4-22-1"/>
      </fig>
      <fig position="float" id="F2">
        <label>Figure 2</label>
        <caption>
          <p>T1 weighted sagital Images with Gd show thrombosis in sagital sinus.</p>
        </caption>
        <graphic xlink:href="1471-2377-4-22-2"/>
      </fig>
      <fig position="float" id="F3">
        <label>Figure 3</label>
        <caption>
          <p>2D MR venogram shows sagital sinus thrombosis.</p>
        </caption>
        <graphic xlink:href="1471-2377-4-22-3"/>
      </fig>
    </sec>
    <sec>
      <title>Pre-publication history</title>
      <p>The pre-publication history for this paper can be accessed here:</p>
      <p>
        <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2377/4/22/prepub"/>
      </p>
    </sec>
  </body>
  <back>
    <ack>
      <sec>
        <title>Acknowledgements</title>
        <p>We are grateful to Mr. Hejrani for secretarial help and Mr. Solimani for preparing the photographs. It should be noted that written consent was obtained from the patient for publication of study.</p>
      </sec>
    </ack>
    <ref-list>
      <ref id="B1">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ameri</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bousser</surname>
              <given-names>MG</given-names>
            </name>
          </person-group>
          <article-title>Cerebral venous sinus thrombosis</article-title>
          <source>Neurol clin</source>
          <year>1992</year>
          <volume>10</volume>
          <fpage>87</fpage>
          <lpage>111</lpage>
          <pub-id pub-id-type="pmid">1557011</pub-id>
        </citation>
      </ref>
      <ref id="B2">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shelley Renowden</surname>
              <given-names/>
            </name>
          </person-group>
          <article-title>Cerebral Venous sinus thrombosis</article-title>
          <source>Eur Radiol</source>
          <year>2004</year>
          <volume>14</volume>
          <fpage>215</fpage>
          <lpage>26</lpage>
          <pub-id pub-id-type="pmid">14530999</pub-id>
          <pub-id pub-id-type="doi">10.1007/s00330-003-2021-6</pub-id>
        </citation>
      </ref>
      <ref id="B3">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shiozawa</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Yamada</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Mabuchic</surname>
              <given-names/>
            </name>
            <name>
              <surname>Hotta</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>saito</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sobue</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Huang</surname>
              <given-names>YP</given-names>
            </name>
          </person-group>
          <article-title>Superior sagital sinus thrombosis associated with androgen therapy for hypoplastic anemia [abstract]</article-title>
          <source>Ann Neurol</source>
          <year>1982</year>
          <volume>12</volume>
          <fpage>578</fpage>
          <lpage>80</lpage>
          <pub-id pub-id-type="pmid">7159062</pub-id>
        </citation>
      </ref>
      <ref id="B4">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jaillard</surname>
              <given-names>AS</given-names>
            </name>
            <name>
              <surname>Hommel</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mallaret</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Venous sinus thrombosis associated with androgens in a healthy young man [abstract]</article-title>
          <source>Stroke</source>
          <year>1994</year>
          <volume>25</volume>
          <fpage>212</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="pmid">8266370</pub-id>
        </citation>
      </ref>
      <ref id="B5">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shahidi</surname>
              <given-names>NT</given-names>
            </name>
          </person-group>
          <article-title>A review of the chemistry, biological action and clinical applications of anabolic androgenic steroids</article-title>
          <source>Clin therap</source>
          <year>2001</year>
          <volume>23</volume>
          <fpage>1355</fpage>
          <lpage>90</lpage>
          <pub-id pub-id-type="pmid">11589254</pub-id>
          <pub-id pub-id-type="doi">10.1016/S0149-2918(01)80114-4</pub-id>
        </citation>
      </ref>
      <ref id="B6">
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wu</surname>
              <given-names>FC</given-names>
            </name>
            <name>
              <surname>Von Eckardstein</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Androgens and coronary artery disease</article-title>
          <source>Endocr Rev</source>
          <year>2003</year>
          <volume>24</volume>
          <fpage>183</fpage>
          <lpage>217</lpage>
          <pub-id pub-id-type="pmid">12700179</pub-id>
          <pub-id pub-id-type="doi">10.1210/er.2001-0025</pub-id>
        </citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
